What is GINA asthma?

Asthma has two key defining features: • a history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity, AND. • variable expiratory airflow limitation.

What is GINA strategy?

The GINA strategy has a strong focus on preventing asthma-related deaths and severe exacerbations, as well as on efficacy and effectiveness for symptom control and lung function, and it promotes personalised treatment decisions across the spectrum of asthma severity.

What is the GINA classification for asthma?

Classification of asthma Previous GINA documents subdivided asthma by severity, based on the level of symptoms, airflow limitation and lung function variability, into four categories: intermittent, mild persistent, moderate persistent or severe persistent (table 2⇓; based on expert opinion rather than evidence).

How often is GINA updated?

The annually updated GINA report is a global, evidence-based strategy that is downloaded each year by clinicians in at least 100 countries. The strategy can be adapted for local use, and the 2019 recommendations have been adopted by at least 35 countries.

What are common asthma symptoms?

Asthma attacks

• wheezing, coughing and chest tightness becoming severe and constant.
• being too breathless to eat, speak or sleep.
• breathing faster.
• a fast heartbeat.
• drowsiness, confusion, exhaustion or dizziness.
• blue lips or fingers.
• fainting.

What kind of document is GINA?

The GINA global strategy for asthma management and prevention is presented in its strategy documents, which are freely available on the GINA Website.

What’s new in asthma treatment?

Mepolizumab (also known as Nucala) is one of the first in a new line of monoclonal antibody treatments designed to treat a specific type of asthma called severe eosinophilic asthma.

What is the first line treatment for asthma?

Beta-agonists are considered first-line therapy for intermittent asthmatics. If frequent use of beta-agonists occurs more than twice a week, controller therapy should be considered. For persistent asthma, low-dose inhaled corticosteroids are recommended in addition to reliever medication.

What is the gold standard for asthma treatment?

It is important to record symptom control, lung function, risk factors, inhalation technique, adherence, and nonpharmacological strategies on a regular basis. The gold standard in asthma therapy is still a low-dose ICS as a controller together with an on-demand Short-acting beta-2-agonist (SABA).

What are interval symptoms in asthma?

Interval symptoms (i.e. experienced between acute flares) such as nocturnal cough, exercise induced wheeze or morning shortness of breath are also typically seen in asthma, and distinguish asthma from viral induced wheeze (below).

When did the Global Initiative for Asthma ( GINA ) start?

The Global Initiative for Asthma (GINA) was launched in 1993 under the auspices of the National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World Health Organization to produce a global strategy on asthma management and prevention. Now constituted as a non-profit en …

Is there a global strategy for asthma management and Prevention?

The 2019 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee.

What was the main report of the Gina?

2021 GINA Main Report 2021 GINA Report, Global Strategy for Asthma Management and Prevention The 2021 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee.

When is World Asthma Day and why is it important?

World Asthma Day (WAD) (May 5, 2021) is organized by the Global Initiative for Asthma, (GINA) ( www.ginasthma.org ), a World Health Organization collaborative organization founded in 1993. WAD is held each May to raise awareness of Asthma worldwide. WHO recognizes that asthma is of major public health importance.